Advertisement

Reactions Weekly

, Volume 1729, Issue 1, pp 133–133 | Cite as

Gefitinib

Interstitial lung disease: case report
Case report
  • 18 Downloads

Reference

  1. Xie H, et al. Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non-Small-Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study. Clinical Lung Cancer 19: 484-492, No. 6, Nov 2018. Available from: URL: http://doi.org/10.1016/j.cllc.2018.05.007 -ChinaCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations